Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pulse Biosciences

14.73
+0.02000.14%
Post-market: 15.300.5650+3.84%18:50 EDT
Volume:115.94K
Turnover:1.71M
Market Cap:990.94M
PE:-14.89
High:15.12
Open:14.85
Low:14.59
Close:14.71
Loading ...

Company Profile

Company Name:
Pulse Biosciences
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
75
Office Location:
601 Brickell Key Drive,Suite 1080,Miami,Florida,United States
Zip Code:
33131
Fax:
- -
Introduction:
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Directors

Name
Position
Paul A. Laviolette
Co-Chairman of the Board, Chief Executive Officer and President
Robert W. Duggan
Co-Chairman of the Board
Darrin R. Uecker
Chief Technology Officer and Director
Mahkam Zanganeh
Independent Director
Manmeet Singh Soni
Lead Independent Director
Richard A. van den Broek
Independent Director

Shareholders

Name
Position
Paul A. Laviolette
Co-Chairman of the Board, Chief Executive Officer and President
Jon Skinner
Chief Financial Officer
Darrin R. Uecker
Chief Technology Officer and Director
Kevin P. Danahy
Chief Commercial Officer
Mitchell E. Levinson
Chief Strategy Officer
Steven T. Weber
Vice President of Accounting and Global Corporate Controller,Principal Accounting Officer
Timothy H. Mitsuoka
Vice President, Corporate Controller and Principal Accounting Officer